Goldfinch Bio, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States
Goldfinch Bio, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $70 million sold in a notice filed in 2020.
Goldfinch Bio at a glance
What does Goldfinch Bio do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $69.7 million sold (2020).
Frequently asked questions about Goldfinch Bio
Where is Goldfinch Bio headquartered?
Goldfinch Bio, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Goldfinch Bio do?
Goldfinch Bio, Inc. is a pharmaceutical company.
When was Goldfinch Bio founded?
The earliest incorporation on record for Goldfinch Bio, Inc. is in 2015, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences